Cencora, Inc. (COR)
- Previous Close
236.57 - Open
234.43 - Bid 235.43 x 900
- Ask 235.56 x 900
- Day's Range
233.58 - 236.70 - 52 Week Range
182.75 - 247.66 - Volume
620,329 - Avg. Volume
1,527,226 - Market Cap (intraday)
46.174B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
25.52 - EPS (TTM)
9.23 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield 2.04 (0.86%)
- Ex-Dividend Date Aug 9, 2024
- 1y Target Est
259.38
Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
www.cencora.com46,000
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: COR
View MorePerformance Overview: COR
Trailing total returns as of 10/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COR
View MoreValuation Measures
Market Cap
46.37B
Enterprise Value
47.79B
Trailing P/E
25.66
Forward P/E
15.77
PEG Ratio (5yr expected)
1.34
Price/Sales (ttm)
0.17
Price/Book (mrq)
50.12
Enterprise Value/Revenue
0.17
Enterprise Value/EBITDA
12.86
Financial Highlights
Profitability and Income Statement
Profit Margin
0.65%
Return on Assets (ttm)
2.85%
Return on Equity (ttm)
187.72%
Revenue (ttm)
283.83B
Net Income Avi to Common (ttm)
1.86B
Diluted EPS (ttm)
9.23
Balance Sheet and Cash Flow
Total Cash (mrq)
3.31B
Total Debt/Equity (mrq)
578.11%
Levered Free Cash Flow (ttm)
4.5B